U.S. Pharmacist Diabetes Update
March 8, 2018

ADA Updates Diagnosis and Classification Standards
Members of the American Diabetes Association's (ADA's) Professional Practice Committee highlight changes in classification and diagnosis in the 2018 Standards of Medical Care in Diabetes. While there are many categories of diabetic diagnoses that most clinicians readily recognize, the ADA reminds healthcare providers that there are still lesser known causes warranting consideration. As diabetic research continues to evolve, limitations of our previous monitoring standards also require greater scrutiny and corrective plan management. Read More.

Diabetes Study Reveals Added Ophthalmic Risks
The risks of uncontrolled diabetes on the eye due to microvascular damage caused by elevated blood glucose are well known. However, a new study highlights additional risks that warrant further consideration and perhaps enhanced screening in diabetic patients. All individuals are at increased risk of cataract formation with advancing age; however, it appears that adults with diabetes over age 40 years are at even greater peril. Read More.

Clinical Trial Assesses Bolus Insulin Dose App
Barriers to using technology to manage diabetes have included concern over the efficacy and reliability of the "newest tools" available. A recent study examines the clinical impact of new speech-recognition software that promotes the goal of modifying bolus doses by calculating a premeal insulin dose based on a voice description of the meal. These findings support the ongoing need to evaluate the efficacy of new technology applications through the use of robust scientific exploration to ensure confidence in both the patient with diabetes and healthcare providers responsible for managing their chronic disease. Read More.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement Advertisement